Results 171 to 180 of about 82,935 (183)
Some of the next articles are maybe not open access.
BRAF Inhibitor Induced Verrucal Keratosis
The American Journal of Dermatopathology, 2014Rachael, Anforth, Pablo, Fernandez-Penas
openaire +2 more sources
Response to BRAF and MEK Inhibitors in BRAF Thr599dup–Mutated Melanoma
JCO Precision Oncology, 2022Marion Oberlé +11 more
openaire +2 more sources
Cutaneous Reactions to BRAF Inhibitors
2015BRAF inhibitors, specifically vemurafenib and dabrafenib, are emerging as first-line treatment for unresectable and/or metastatic BRAF mutated melanoma due to their superior efficacy and improved survival statistics. While better tolerated than previously used treatment options, they carry high rates of cutaneous reactions, with most BRAF-inhibitor ...
openaire +1 more source
BRAF inhibitor therapy of primary ameloblastoma
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2016Serena, Tan +4 more
openaire +2 more sources
Commentary: BRAF inhibitors for metastatic melanoma
British Journal of Dermatology, 2013openaire +2 more sources
[BRAF inhibitor and MEK inhibitor].
Gan to kagaku ryoho. Cancer & chemotherapy, 2015openaire +1 more source